Proteogenomics Provides New Insights into Pancreatic Ductal Adenocarcinoma | Office of Cancer Clinical Proteomics Research
Recent advances in precision medicine for pancreatic ductal adenocarcinoma - Hayashi - 2021 - Annals of Gastroenterological Surgery - Wiley Online Library
PANCREATIC CANCER :: Molecular pathology of pancreatic diseases
Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma | Experimental Hematology & Oncology | Full Text
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
Oncotarget | Prognostic and predictive factors in pancreatic cancer | Oncotarget
Cureus | Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances | Article
Pancreatic ductal adenocarcinoma subtypes: what your type means? | Fred Hutchinson Cancer Center
PANCREATIC CANCER :: Molecular pathology of pancreatic diseases
Frontiers | Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Cancers | Free Full-Text | Mucins and Pancreatic Cancer
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
Genetic progression model of pancreatic carcinogenesis. The main... | Download Scientific Diagram
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | European Surgery
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma - ScienceDirect
Pancreatic Cancer Stem Cell Marker May Aid Potential Treatments | Technology Networks
Frontiers | Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule | Journal of Medicinal Chemistry
Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate
Cells | Free Full-Text | Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | European Surgery
Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer - eBioMedicine
Frontiers | Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
